Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Jan 16 2026
Dec 19 2025
Nov 17 2025
Apr 24 2025
Sep 3 2025